
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Robert Andtbacka, MD, associate professor, Division of Surgical Oncology, Department of Surgery, University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Rigors and chills are quite common, but can be managed fairly easily. If a patient experiences these side effects, Andtbacka says, a physician should premeditate him or her with Tylenol and antihistamines in future treatments. After 5-7 injections, the side effects usually go away completely.
Overall, T-VEC is very well tolerated and most patients can go to work and continue with other everyday activities.






